Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Curti

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Adoptive immunotherapyB D Curti
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Adoptive immunotherapyB D Curti
Critical Reviews in Oncology/Hematology|February 1, 1993
Physical barriers to drug delivery in tumorsB D Curti
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
Adoptive immunotherapyB D Curti
Pharmacology & Therapeutics|March 1, 1995
Interleukin-1 in the treatment of cancerB D Curti, J W Smith
American Journal of Clinical Pathology|January 14, 1998
Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virusA O Vortmeyer, D W Kingma, R G Fenton, et al.
American Journal of Hematology|March 12, 1998
Development of rheumatoid arthritis after treatment of large granular lymphocyte leukemia with deoxycoformycinJ Yoe, B L Gause, B D Curti, et al.
Cancer Research|May 15, 1993
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatmentB D Curti, W J Urba, W G Alvord, et al.
The Cancer Journal From Scientific American|March 4, 2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemiaB Arun, B D Curti, D L Longo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Interleukin 1 alpha increases serum leptin concentrations in humansJ E Janik, B D Curti, R V Considine, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Adoptive immunotherapyB D Curti
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Adoptive immunotherapyB D Curti
Critical Reviews in Oncology/Hematology|February 1, 1993
Physical barriers to drug delivery in tumorsB D Curti
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
Adoptive immunotherapyB D Curti
Pharmacology & Therapeutics|March 1, 1995
Interleukin-1 in the treatment of cancerB D Curti, J W Smith
American Journal of Clinical Pathology|January 14, 1998
Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virusA O Vortmeyer, D W Kingma, R G Fenton, et al.
American Journal of Hematology|March 12, 1998
Development of rheumatoid arthritis after treatment of large granular lymphocyte leukemia with deoxycoformycinJ Yoe, B L Gause, B D Curti, et al.
Cancer Research|May 15, 1993
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatmentB D Curti, W J Urba, W G Alvord, et al.
The Cancer Journal From Scientific American|March 4, 2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemiaB Arun, B D Curti, D L Longo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Interleukin 1 alpha increases serum leptin concentrations in humansJ E Janik, B D Curti, R V Considine, et al.
Pageof 3